Ardelyx, Inc. (ARDX)
3.28
+0.01
(+0.31%)
USD |
NASDAQ |
Oct 09, 16:00
3.275
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Free Cash Flow (Quarterly) : -6.412M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.412M |
| March 31, 2026 | -32.31M |
| December 31, 2025 | 20.59M |
| September 30, 2025 | 0.209M |
| June 30, 2025 | -25.99M |
| March 31, 2025 | -38.78M |
| December 31, 2024 | 9.217M |
| September 30, 2024 | 0.364M |
| June 30, 2024 | -19.53M |
| March 31, 2024 | -35.87M |
| December 31, 2023 | -8.761M |
| September 30, 2023 | -21.66M |
| June 30, 2023 | -14.83M |
| March 31, 2023 | -44.81M |
| December 31, 2022 | 14.23M |
| September 30, 2022 | -25.43M |
| June 30, 2022 | -31.28M |
| March 31, 2022 | -27.62M |
| December 31, 2021 | -39.37M |
| September 30, 2021 | -35.03M |
| June 30, 2021 | -35.02M |
| March 31, 2021 | -45.00M |
| December 31, 2020 | -17.84M |
| September 30, 2020 | -19.93M |
| June 30, 2020 | -19.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -24.97M |
| December 31, 2019 | -11.14M |
| September 30, 2019 | -20.73M |
| June 30, 2019 | -27.87M |
| March 31, 2019 | -17.08M |
| December 31, 2018 | -18.72M |
| September 30, 2018 | -26.99M |
| June 30, 2018 | -18.02M |
| March 31, 2018 | -6.859M |
| December 31, 2017 | 4.67M |
| September 30, 2017 | -19.46M |
| June 30, 2017 | -24.88M |
| March 31, 2017 | -27.88M |
| December 31, 2016 | -29.32M |
| September 30, 2016 | -26.44M |
| June 30, 2016 | -25.20M |
| March 31, 2016 | -16.45M |
| December 31, 2015 | -22.06M |
| September 30, 2015 | -12.48M |
| June 30, 2015 | -31.49M |
| March 31, 2015 | -9.264M |
| December 31, 2014 | -4.824M |
| September 30, 2014 | -5.773M |
| June 30, 2014 | |
| March 31, 2014 |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -37.39M |
| REGENXBIO, Inc. | -63.00M |
| Compass Therapeutics, Inc. | -14.91M |
| ARS Pharmaceuticals, Inc. | -60.93M |
| Sionna Therapeutics, Inc. | -22.22M |